Copeptin as a marker of outcome after cardiac arrest: a sub-study of the TTM trial

Copeptin as a marker of outcome after cardiac arrest: a sub-study of the TTM trial

Abstract Background Arginine vasopressin has complex actions in critically ill patients, involving vasoregulatory status, plasma volume, and cortisol levels. Copeptin, a surrogate marker for arginine vasopressin, has shown promising prognostic features in small observational studies and is used clin...

Full description

Bibliographic Details
Main Authors: Joachim Düring, Martin Annborn, Tobias Cronberg, Josef Dankiewicz, Yvan Devaux, Christian Hassager, Janneke Horn, Jesper Kjaergaard, Michael Kuiper, Homa Rafi Nikoukhah, Pascal Stammet, Johan Undén, Michael Jaeger Wanscher, Matt Wise, Hans Friberg, Niklas Nielsen
Format: Article
Language:English
Published: BMC 2020-04-01
Series:Critical Care
Subjects:
Humans
Copeptin
Arginine vasopressin
AVP protein human
Out-of hospital cardiac arrest
Biomarkers
Online Access:http://link.springer.com/article/10.1186/s13054-020-02904-8

Internet

http://link.springer.com/article/10.1186/s13054-020-02904-8

Similar Items